Impact Of High Pneumonia Prevalence On Vaccine Demand: A Key Factor Shaping the Future of the Vaxneuvance Market in 2025

"What Are the Projections for the Size and Growth Rate of the Vaxneuvance Market?
The market size of vaxneuvance has experienced a $XX (CAGR) growth in recent years. Forecasts show that it will expand from $XX million in 2024 to $XX million in 2025, with a compound annual growth rate (CAGR) of $XX%. This growth trajectory in the historic period is attributed to the increasing prevalence of pneumococcal diseases, surge in aging population, elevated levels of supportive regulatory approvals, increased government funding for vaccination, and the rise of travel and globalization.

The market size of vaxneuvance is predicted to witness a surge of $XX (CAGR) in the coming years, escalating to $XX million by 2029 with a compound annual growth rate (CAGR) of $XX%. This expected growth during the forecast period can be ascribed to an increase in chronic diseases, increased antibiotic resistance, heightened respiratory infections in children, a rise in the count of immunocompromised individuals, and increased funding in healthcare. The forthcoming period will see predominant trends like the evolution of needle-free systems for vaccine delivery, advancements in technologies used for cold-chain, incorporation of AI-powered supply chain enhancement, integration into digital health records for immunization tracking, and breakthroughs in adjuvant systems that amplify the immune reaction.

What Are the Main Catalysts for Growth in the Vaxneuvance Market?
The vaxneuvance market is forecasted to expand due to the increasing incidence of pneumonia. Pneumonia, a medical condition characterized by the inflammation of air sacs in either one or both lungs, which may be filled with fluid or pus, can cause symptoms like coughing, fever, and difficulty in breathing. Factors contributing to the rise in pneumonia cases include viral and bacterial infections, compromised immune systems, air pollution, and the growing number of elderly people who are more prone to respiratory infections. Vaxneuvance can aid patients by providing protection against pneumonia due to 15 types of Streptococcus pneumoniae, diminishing the chance of severe infections and associated complications. For example, the Johns Hopkins University, a research university in the US, reported that the average Pneumonia GAPPD (Global Action Plan for Pneumonia and Diarrhea) score across 15 countries rose 2% from 54% to 56% in 2024. Thus, the escalating incidence of pneumonia is propelling the vaxneuvance market's growth.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20428&type=smp

Which Businesses Are at the Forefront of Vaxneuvance Market Development?
Major companies operating in the vaxneuvance market are Merck & Co. Inc.

What Are the Latest Innovations in the Vaxneuvance Market?
A principal trend in the vaxneuvance market is the expansion of vaccine indications to cater to a wider patient base. Enhanced indications fulfill unmet medical requirements and heighten the vaccine's efficacy in battling pneumococcal diseases in various age clusters. For example, Merck & Co. Inc., a pharmaceutical corporation based in the US, declared in June 2022 that the United States Food and Drug Administration (FDA) widened the vaxneuvance approval to children from 6 weeks to 17 years old, to prevent invasive pneumococcal disease from 15 serotypes. Although this approval emphasizes its clinical importance, it warns against usage in individuals with intense allergies to its components.

How Is the Vaxneuvance Market Segmented?
The vaxneuvance market covered in this report is segmented -

1) By Indication: Pneumonia; Meningitis; Sepsis; Bacteremia; Otitis Media
2) By Distribution Channel: Pharmacies; Hospitals
3) By End User: Adults; Children; Geriatric Population

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/vaxneuvance-global-market-report

Where Is the Vaxneuvance Market Growth Most Prominent?
North America was the largest region in the vaxneuvance market in 2024. The regions covered in the vaxneuvance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Vaxneuvance Global Market Report?

- Market Size Analysis: Analyze the vaxneuvance Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the vaxneuvance Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the market.
- Market Contribution: Evaluate contributions of different segments to the overall vaxneuvance market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the vaxneuvance market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20428

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.